Competitive Problems in the Drug Industry The Risks and Benefits of Oral Contraceptives

Format:

Book

Government document

Author/Creator:

Library of Congress. Congressional Research Service

Language:

English

Subjects (All):

Cancer.

Contraceptives.

Drugs.

Physical Description:

1 online resource

Contained In:

ProQuest U.S. Congressional Research Digital Collection

Place of Publication:

[Washington, D.C.] [publisher not identified] 1978

Summary:

Appendices (pages 62-124) include:

CRS report, prepared by Vikki A. Zegel and Blanchard Randall IV for the Subcom on Monopoly and Anticompetitive Activities, reviewing major issues raised during 1970 subcom hearings to consider the safety of oral contraceptives

Summarizes 1970 testimony (topical index, pages 64-67) and subsequent findings regarding the relationship of oral contraceptives to circulatory disorders, hypertension, cancer, liver disease, and other health problems. Also examines FDA regulation of oral contraceptives marketing and labeling

Notes:

CRS Report

Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed June 2010). Reuse except for individual research requires license from ProQuest, LLC

Vendor supplied data

Other Format:

Microfiche version Library of Congress. Congressional Research Service. Competitive Problems in the Drug Industry:. 78-S722-11

Publisher Number:

CRS-1978-SPR-0051

Access Restriction:

Restricted for use by site license